Overview

A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is evaluating stereotactic radiosurgery (CyberKnife) plus chemotherapy for the treatment of potentially resectable adenocarcinoma of the pancreas
Phase:
Early Phase 1
Details
Lead Sponsor:
The Cooper Health System
Treatments:
Gemcitabine